Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.765%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
GELN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding - Grant of options

13 Dec 2023 07:00

RNS Number : 5625W
Gelion PLC
13 December 2023
 

13 December 2023

Gelion PLC

(the "Company" or the "Group")

Director/PDMR Shareholding - Grant of options 

Gelion plc (AIM: GELN), the Anglo-Australian energy storage innovator, announces the grant of options ("Options") to subscribe for new ordinary shares ("Ordinary Shares") to Amit Gupta, Chief Financial Officer, in accordance with the terms of the Group's Share Option Plan.

 

Mr Gupta was granted 259,370 Options on 13 December 2023. These Options have an exercise price of 0.1 pence and are subject to vesting and exercise conditions of the Share Option Plan as set out below. Following this grant the total number of Options held by Amit Gupta is 695,802. These Options have been granted to Mr Gupta in recognition of his contributions to the Group in FY23.

Subsequent to this issue of Options, the Group has approximately 11.04 million Options in issue, representing 8.1% of the Company's issued share capital.

Summary of terms of these Options

These Options will vest in three equal tranches with the final vesting on 31 August 2026 provided on each vesting that Mr Gupta is in continuous employment with Gelion. The Options expire, to the extent that they have not been exercised, on 13 December 2033.

All Options are subject to both malus and clawback provisions and good and bad leaver provisions. All unvested options will vest in certain corporate events such as a takeover of the company or a change of control. In these circumstances the Options would normally vest and become exercisable in full unless the Board decides that the Option will be pro-rated to take account of the date the corporate event took place during the normal vesting period.

Enquiries:

 

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

via Alma

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Neil McDonald

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 

Alma Strategic Communications

Justine James

Hannah Campbell

Will Ellis Hancock

+44 20 3405 0205

gelion@almastrategic.com

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Amit Gupta

2. 

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Gelion plc

b)

LEI:

2138008NC7YL3MCUDR84

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1p each ("Ordinary Shares")

GB00BNBQZD59

b)

Nature of the transaction:

Grant of options 

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

0.1p

259,370

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 (c) above 

e)

Date of the transaction:

13 December 2023

f)

Place of the transaction:

Outside of a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDDBDDIXBDGXD
12
Date   Source Headline
24th Apr 20248:30 amRNSMello Investor Presentation
4th Apr 20247:00 amRNSLi-S Cell High Energy Density Milestone Achieved
27th Mar 20247:00 amRNSInterim results to 31 December 2023
20th Mar 202410:09 amRNSNotice of Results and Investor Presentation
19th Mar 20247:00 amRNSLithium-Sulfur Battery development update
5th Feb 20247:00 amRNSSenior Leadership Team Appointments
29th Jan 20247:00 amRNSBlock Admission Return
16th Jan 202411:27 amRNSResult of General Meeting
22nd Dec 202310:41 amRNSExercise of Options, Director Shareholding & TVRs
21st Dec 202312:23 pmRNSResult of AGM
14th Dec 20234:15 pmRNSPosting of Annual Report and Notice of GM
13th Dec 20237:00 amRNSDirector/PDMR Shareholding - Grant of options
12th Dec 202312:00 pmRNSFinal results to 30 June 2023
1st Dec 20237:00 amRNSDirector/PDMR Dealings and Total Voting Rights
30th Nov 202312:40 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSNotice of Results and AGM
27th Nov 20234:54 pmRNSResult of GM and Total Voting Rights
23rd Nov 20237:01 amRNSNotice of Investor Presentation
23rd Nov 20237:00 amRNSResult of Retail Offer and Total Voting Rights
21st Nov 20237:00 amRNSGelion and Ionblox JDA signed
9th Nov 20231:00 pmRNSResult of Placing and Posting of Circular
9th Nov 20238:00 amRNSUK Retail Offer
9th Nov 20237:17 amRNSProposed Acquisition, Placing, Retail Offer and GM
11th Oct 20237:00 amRNSExpanded Li-S R&D Facility launched
15th Aug 20237:00 amRNSTrading update and two new agreements signed
27th Jul 20239:45 amRNSBlock Admission Return
6th Jul 20237:00 amRNSZinc battery solution and Lithium Sulfur update
5th Jul 20237:00 amRNSChange of Registered Office
1st Jun 202312:05 pmRNSDirector/PDMR Shareholding
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20237:19 amRNSStrategic progress on Johnson Matthey IP acq
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20239:15 amRNSDirector/PDMR Shareholding
17th Mar 202310:45 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim results to 31 December 2022
13th Mar 20237:00 amRNSLithium Sulfur IP Acq + Innovation Challenge
9th Mar 20237:00 amRNSAcq. of Johnson Matthey’s battery IP portfolio
1st Mar 20238:17 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSNotice of Results and Investor Presentation
27th Jan 20237:00 amRNSBlock Admission Return
16th Dec 202212:00 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSCEO Board Appointment and Grant of Options
9th Dec 202211:29 amRNSResult of AGM
6th Dec 20229:30 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSProof of performance additive viability
30th Nov 20229:50 amRNSDirector/PDMR Shareholding - Grant of options
24th Nov 202211:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:00 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20227:01 amRNSFinal results to 30 June 2022
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.